TWIST1 and colorectal cancer: Reversing epithelial–mesenchymal transition (EMT) represents another avenue: the small−molecule reversine inhibits Twist1 nuclear translocation, reestablishing 5-fluorouracil sensitivity in colorectal cancer cells by restoring epithelial characteristics (109, 136, 137).